CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

/C O R R E C T I O N -- Bridge to Life, Ltd./

RegulatoryapprovedVitaSmart™ Hypothermic Oxygenated Perfusion SystemPositive
AI Analysis

Summary

UK NICE issued guidance recommending routine NHS funding for Bridge to Life's VitaSmart Hypothermic Oxygenated Perfusion System. This is a correction notice regarding the original announcement.

Outcome Details

UK NICE issued guidance recommending routine NHS funding

Importance:6/10
Sentiment:
0.80
regulatory approvalNICE guidanceNHS fundingmedical deviceUK

Read the original article

Published by PR Newswire Biotech on August 27, 2026 9:18 PM

Read Original